Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-Label Extension of ULTIMATE I and II StudiesBruce A. C. Cree,Edward Fox,Hans Peter Hartung,Enrique Alvarez,Peiqing Qian,Sibyl Wray,Derrick Robertson,Deren Huang,Krzysztof Selmaj,Daniel Wynn,Koby Mok,Yanzhi Hsu,Yihuan Xu,Chris Rowland,Karthik Bodhinathan,Peter Sportelli, Jackie Parker,Hari Miskin,Lawrence SteinmanMULTIPLE SCLEROSIS JOURNAL（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
